| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 09/24/2009 | WO2009085828A3 Quinine sulfate polymorphs, processes of preparing, compositions and uses thereof |
| 09/24/2009 | WO2009035160A8 Candidate molecule for falciparum malaria vaccine |
| 09/24/2009 | WO2008030119A9 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 09/24/2009 | US20090239900 Quinine and quinidine salts, methods for making them, and pharmaceutical formulations comprising them |
| 09/24/2009 | US20090239885 Inhibitors of nucleoside phoshorylases and nucleosidases |
| 09/24/2009 | US20090239871 antitumor; breast cancer; 8,9-Dimethoxy-2,3-methylenedioxy-5-[2-(N,N-dimethylamino)ethyl]-5H-dibenzo[c,h]1,6-naphthyridin-6-one |
| 09/24/2009 | DE102008015250A1 Neue Medikamenten Synthese New drug synthesis |
| 09/24/2009 | CA2714184A1 Combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria |
| 09/23/2009 | EP2103598A1 Fluorinated cycloalkyl-derived benzoylguanidine, method for producing same, use of same as medicine and medicine containing same |
| 09/23/2009 | CN101538520A Tricholoma matsutake wine |
| 09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/23/2009 | CN101537064A Formulation method for treating chicken colibacillosis and pullorosis |
| 09/23/2009 | CN101537063A Formulation method for treating chicken dysentery and toxic heat |
| 09/23/2009 | CN101537044A Neem oil microemulsion and application thereof |
| 09/23/2009 | CN101536983A Albendazole oxide hydrochloride premix for animals |
| 09/23/2009 | CN100542612C Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 09/23/2009 | CN100542606C Vaccine composition comprising tumour antigen and adjuvant composition |
| 09/22/2009 | US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate |
| 09/22/2009 | CA2419588C Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 09/22/2009 | CA2372664C Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa |
| 09/17/2009 | WO2009113569A1 Medicinal composition containing benzo[a]phenoxanthin compound as the active ingredient for preventing or treating protozoal disease |
| 09/17/2009 | CA2718364A1 A topical ectoparasiticide composition |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/15/2009 | US7589127 Aminoalkylphenols, methods of using and making the same |
| 09/15/2009 | US7589099 Condensation of 7-t-butoxyiminomethylcamptothecin in position 20 with a cyclopeptide containing the RGD sequence; selective cytotoxic activity on human tumor cell lines; antitumor; |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | CA2616765C Control of parasitic infestations in farmed and wild fish |
| 09/15/2009 | CA2421683C Microparticles for delivery of the heterologous nucleic acids |
| 09/15/2009 | CA2334675C Control of parasitic infestations in farmed and wild fish |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/11/2009 | WO2009109989A1 A novel process for the preparation of ethers of dihydroartemisinin |
| 09/11/2009 | WO2009086471A3 Synergistic antiparasitic compositions and screening methods |
| 09/10/2009 | US20090227538 N-(Hetero)Aryl Indole Derivatives as Pesticides |
| 09/10/2009 | US20090226445 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/09/2009 | EP2097409A1 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhbitors |
| 09/09/2009 | EP1519724B1 Fredericamycin derivatives as medicaments for treating tumours |
| 09/09/2009 | EP1515947B1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 09/09/2009 | EP1371370B1 Drugs containing reduced vitamin b2 |
| 09/09/2009 | EP1279735B1 Malaria plasmodium antigen polypeptide se36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 09/09/2009 | CN101525625A Clone, expression and application of mutase gene in Schistosoma japonicum phosphoglyceric acid |
| 09/09/2009 | CN101524547A DNA vaccine for preventing and treating cysticercosis cellulosae and preparation method thereof |
| 09/09/2009 | CN101524499A Gynecological lotion and preparation method thereof |
| 09/09/2009 | CN101524462A Garlic volatile oil composition, preparation method of cream preparation thereof and application of cream preparation to treating microbial infection of skin and mucous membrane |
| 09/09/2009 | CN101524430A Traditional Chinese fish drug |
| 09/09/2009 | CN101524367A Method for preparing discolored iodine tincture and application thereof |
| 09/09/2009 | CN101524351A Treating infectious diseases by administering an ICE inhibitor |
| 09/08/2009 | US7585947 IL-7 drug substance, composition, preparation and uses |
| 09/08/2009 | US7585511 Apolipoprotein L-I and/or derivated polypeptide for the treatment of and/or the prevention of diseases induced by trypanosoma |
| 09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
| 09/03/2009 | WO2009106211A1 Beta-lactones as antibacterial agents |
| 09/03/2009 | WO2009087474A3 Agonists for antimicrobial peptide systems |
| 09/03/2009 | WO2008077522A3 Use of polypeptides as coccidiostat and /or histomonastat |
| 09/03/2009 | US20090221524 Odcase inhibitors for the treatment of malaria |
| 09/03/2009 | US20090220547 Reducing interference between oil-containing adjuvants and surfactant-containing antigens |
| 09/02/2009 | EP2094722A1 Use of polypetides against diseases caused by protozoans |
| 09/02/2009 | EP2094711A1 Structural mimetics of proline-rich peptides and the pharmaceutical use thereof |
| 09/02/2009 | EP1005368B1 Use of nucleic acids containing unmethylated CpG dinucleotide in combination with alum as adjuvants |
| 09/02/2009 | CN101518652A Preparation method of toltrazuril-cyclodextrin inclusion compound |
| 09/02/2009 | CN101518570A Use of protopine total alkaloids in animal drugs for economic animals |
| 09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
| 09/01/2009 | US7582613 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 09/01/2009 | CA2420640C Combination preparations of 3-n-formyl hydroxy amino propyl phosphonic acid derivatives or 3-n-acetyl hydroxy amino propyl phosphonic acid derivatives together with special pharmaceutical active ingredients |
| 09/01/2009 | CA2327434C Dna immunization against chlamydia infection |
| 08/27/2009 | WO2009105355A2 A novel neospora caninum vaccine |
| 08/27/2009 | WO2009103901A2 Pharmaceutical composition containing an n‑phenylpyrazole derivative and glycofurol, use for the preparation of a topical veterinary medicament for combating fleas |
| 08/27/2009 | US20090215678 Preventing Vertical Endoparasite Infections |
| 08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
| 08/27/2009 | US20090214635 Identification of a conserved region of plasmodium falciparum msp3 targeted by biologically active antibodies |
| 08/27/2009 | DE202008017304U1 Oral zerfallender Film zur therapeutischen Anwendung von Antiparasitika bei Tieren Oral disintegrating film for the therapeutic use of antiparasitic agents in animals |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2093214A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 08/26/2009 | EP2093207A1 Antiinfective and antitumoral compounds isolated from tropical lianas |
| 08/26/2009 | EP2091554A2 Use of polypeptides as coccidiostat and /or histomonastat |
| 08/26/2009 | EP1835912B1 Substituted benzimidazoles for treatment of histomoniasis |
| 08/26/2009 | EP1530584B1 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 08/26/2009 | EP1012187B1 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
| 08/26/2009 | CN101516858A Crystalline antifungal compounds |
| 08/26/2009 | CN101516377A New medical use of triazine derivatives |
| 08/26/2009 | CN101513401A Application of beta-m-dihydroxy-benzoic acid macrocyclic lactone derivative in prevention of malaria |
| 08/26/2009 | CN100531728C Use of neuron sodium ion pass antagonist for controlling homothermal animal ectoparasite |
| 08/25/2009 | US7579325 Drugs containing reduced of vitamin B2 |
| 08/25/2009 | US7579009 a whole cell of a bacterium from the genera Rhodococcus, Gordonia, Nocardia, Dietzia, Tsukamurella and Nocardioides and at least one antigen or antigenic determinant; tuberculosis and leishmaniasis; vaccines |
| 08/25/2009 | CA2413775C A combination kit used in the treatment of malaria |
| 08/20/2009 | WO2009102497A2 Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 08/20/2009 | WO2009100489A1 Crystal structure of pfa-mi and the pfa-mi co4 complex |
| 08/20/2009 | WO2009071905A3 Use of thiolatocobalamins as regulators/selective promoters of inducible and constitutive nitric oxide synthases |
| 08/20/2009 | US20090209593 Novel antibacterial agents |
| 08/20/2009 | US20090209557 Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity |
| 08/20/2009 | US20090208536 Composition comprising fractions or sub-fraction of leishmania promastigotes or leishmania amastigotes called fucose mannose ligand (fml) and saponin, composition for preparation of leishmaniasis transmission blocking vaccines in humans and animals comprising fractions or sub-fractions of leishmania promastigotes or leis |
| 08/20/2009 | US20090208476 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
| 08/20/2009 | CA2715294A1 Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 08/19/2009 | EP1485393B1 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives |
| 08/19/2009 | EP1175226B1 Lipoglycan compositions and methods of treating parasitic infections |
| 08/19/2009 | EP1137639B1 Control of arthropods in animals |
| 08/19/2009 | CN101511795A 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
| 08/19/2009 | CN101508999A Recombinant toxoplasma protein and uses thereof |
| 08/19/2009 | CN101508692A Anthranilamides, process for the production thereof, and pest controllers containing the same |
| 08/19/2009 | CN100528240C Preparation method and medicinal uses of Trichinella eelworm vaccine |
| 08/19/2009 | CN100528225C Methods for the in vitro culture of sporozoea species and uses thereof |
| 08/18/2009 | US7575755 Method of inducing an immune response to a parasite utilising an immunogenic composition comprising a glycosylphosphatidylinositol (referred to herein as "GPI") inositolglycan domain or its derivative or equivalent |